Co-Diagnostics shareholders approve 6M share increase for LTIP; re-elect directors

Co-Diagnostics, Inc.

Proposal to increase share reserve under 2015 LTIP by 6,000,000 shares approved (7,646,908 for, 4,863,908 against).
Class I directors Edward L. Murphy and Richard S. Serbin re-elected with over 8.3M votes each.
Advisory vote on executive compensation passed: 11,540,967 for, 919,014 against.
Ratification of Haynie & Company as independent auditor for FY2022 passed: 20,879,301 for, 298,712 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.